Yüklüyor......
A132 ANTI-TNF DOSE AUGMENTATION FREQUENTLY OCCURS IN THE ABSENCE OF OBJECTIVE EVIDENCE OF DISEASE ACTIVITY
BACKGROUND: Anti-TNF dose is frequently increased or dosing interval shortened in IBD subjects with persistent gastrointestinal symptoms. Evidence supporting dose augmentation is of low quality and the practice imparts a significant additional cost of care. Persons with symptoms ascribed to IBD may...
Kaydedildi:
| Yayımlandı: | J Can Assoc Gastroenterol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512673/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.131 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|